| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 35 |
| 1 | NIVOLUMAB | 16 |
| 2 | CABOZANTINIB | 15 |
| 3 | LENVATINIB | 12 |
| 4 | PAZOPANIB HYDROCHLORIDE | 11 |
| 5 | AXITINIB | 7 |
| 6 | DEXAMETHASONE | 6 |
| 7 | DEXAMETHASONE 1.5 MG | 6 |
| 8 | EVEROLIMUS | 6 |
| 9 | MYCOPHENOLATE MOFETIL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOMEPIZOLE | 1 | 0.0053 |
| 1 | VADADUSTAT | 1 | 0.0033 |
| 2 | L-LYSINE | 1 | 0.0014 |
| 3 | ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS | 1 | 0.0009 |
| 4 | BELZUTIFAN | 1 | 0.0006 |
| 5 | PAZOPANIB HYDROCHLORIDE | 11 | 0.0004 |
| 6 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 7 | AXITINIB | 7 | 0.0004 |
| 8 | LENVATINIB | 12 | 0.0004 |
| 9 | ETELCALCETIDE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 51 | 0.0005 |
| 3 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Kinase Inhibitor [EPC] | 31 | 0.0001 |